Sabrina Johnson Daré Bioscience's guest appearances

Sabrina Johnson Daré Bioscience

Empowered Patient Podcast

Mark Allen

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

Robin Zander

OwlTail

Sabrina Johnson

Sabrina Johnson is the Founder, President, and CEO of Daré Bioscience. Sabrina points out that there are several unmet needs in women's health and that many of the indications or conditions that women are dealing with are not life-threatening but affect their quality of life. Applying technologies created by smaller companies and academic institutions, Daré aims to become a pipeline for companies that have a global commitment to improving women's health. Sabrina explains, "Our business model is to really be that innovation accelerator that starts with finding and identifying that persistent unmet need. And that's where we start. What is that condition that is not adequately addressed today for her? Developing a target product profile, what would the product look like that might be best suited to address that condition for her? We then go out and look for a technology that has a proof of concept that it should address that and hit that target product profile. We bring that into Daré into our portfolio. We advance it through development, and then ultimately, we seek to bring that product to market in whatever way makes the most sense for that product. And sometimes that's going to be by being that pipeline resource to companies like Bayer and Organon. And I mentioned both of those because we have a collaboration with each of them now." @DareBioscience #WomensHealth #GenderInequality #Healthcare #ReproductiveHealth #SexualHealth #Biotech #DrugDevelopment darebioscience.com Download the transcript here

Sabrina Johnson is the Founder, President, and CEO of Daré Bioscience. Sabrina points out that there are several unmet needs in women's health and that many of the indications or conditions that women are dealing with are not life-threatening but affect their quality of life. Applying technologies created by smaller companies and academic institutions, Daré aims to become a pipeline for companies that have a global commitment to improving women's health. Sabrina explains, "Our business model is to really be that innovation accelerator that starts with finding and identifying that persistent unmet need. And that's where we start. What is that condition that is not adequately addressed today for her? Developing a target product profile, what would the product look like that might be best suited to address that condition for her? We then go out and look for a technology that has a proof of concept that it should address that and hit that target product profile. We bring that into Daré into our portfolio. We advance it through development, and then ultimately, we seek to bring that product to market in whatever way makes the most sense for that product. And sometimes that's going to be by being that pipeline resource to companies like Bayer and Organon. And I mentioned both of those because we have a collaboration with each of them now." @DareBioscience #WomensHealth #GenderInequality #Healthcare #ReproductiveHealth #SexualHealth #Biotech #DrugDevelopment <a href="http://darebioscience.com" rel="noopener nofollow" target="_blank">darebioscience.com</a> <a href="http://empoweredpatientradio.com/investing-in-and-growing-healthcare-products-for-women-with-sabrina-johnson-dar-bioscience-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a>

Investing in and Growing Healthcare Products for Women with Sabrina Johnson Daré Bioscience